9 reports

(France) ##.

  • Allergy Drug
  • OTC
  • Pharmaceutical
  • Respiratory Treatment
  • World

Core operating income was USD ##. ## billion (-##%, +##% cc).

  • Pulmonary Delivery
  • Respiratory Treatment
  • United States
  • Company Financials
  • GlobalData's company

Neupogen (filgrastim) ##.

  • Respiratory Treatment
  • United States
  • Demand
  • AstraZeneca PLC
  • Roche Group
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Pharmaceutical
  • Respiratory Disease
  • Respiratory Treatment
  • World
  • 3. GDCT ID IS THE UNIQUE ID OF GLOBALDATA'S PHARMA INTELLIGENCE CENTER CLINICAL TRIAL DATABASE

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Pharmaceutical
  • Respiratory Disease
  • Respiratory Treatment
  • World
  • Clinical Trial profile. 1603 Trial Title
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

Boehringer Sohn AG & Co KG ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Teva Pharmaceutical Industries Ltd F.

  • Asthma
  • Clinical Trial
  • Pharmaceutical
  • Respiratory Treatment
  • World
  • Clinical Trial Profile Snapshots

The prominent features of this report are - ##.

  • Clinical Trial
  • Hospital
  • Pharmaceutical
  • Respiratory Treatment
  • World

KG ## ## ## ## ## ## ## ## Allosteros Therapeutics Inc. ## ## ## ## ## ## ## ## Aquinox Pharmaceuticals Inc. ## ## ## ## ## ## ## ## ASIT biotech s. a. ## ## ## ## ## ## ## ## Aslan Pharmaceuticals Pte.

  • Respiratory Disease
  • Respiratory Treatment
  • Therapy
  • United States
  • Infinity Pharmaceuticals, Inc.

Infliximab by Nippon Kayaku (approved in 2014) and Filgrastim by Teva Pharma Japan (approved in 2013) are some of the drugs of this segment.

  • Anti-Infective
  • Respiratory Treatment
  • Japan
  • Meiji Seika Pharma Co., Ltd.
  • Nipro Corporation